3.48
+0.08(+2.35%)
Currency In USD
| Previous Close | 3.4 |
| Open | 3.4 |
| Day High | 3.6 |
| Day Low | 3.39 |
| 52-Week High | 7.63 |
| 52-Week Low | 2.37 |
| Volume | 1.13M |
| Average Volume | 1.15M |
| Market Cap | 440.77M |
| PE | -38.67 |
| EPS | -0.09 |
| Moving Average 50 Days | 3.24 |
| Moving Average 200 Days | 4.85 |
| Change | 0.08 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $185.5 as of July 02, 2025 at a share price of $3.48. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $316.94 as of July 02, 2025 at a share price of $3.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
GlobeNewswire Inc.
May 29, 2025 9:00 PM GMT
Improved Sample Throughput, Automation Capabilities and Updated Hardware Design Cytek Aurora™ Evo Cytek today unveiled the Cytek Aurora™ Evo system, a full spectrum flow cytometer that builds on the trusted performance of the Cytek Aurora system. D
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 8:05 PM GMT
FREMONT, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Confe
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
GlobeNewswire Inc.
Apr 29, 2025 9:00 PM GMT
Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry EventsFREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcas